Group Management Lp Column serves as Executive at NGM BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Group Management Lp Column has executed 11 insider transactions totaling $32.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 28, 2020 involved purchasing 4,105 shares valued at $73.8K.
Group Management Lp Column currently holds 1,616,952 shares of NGM BIOPHARMACEUTICALS INC (NGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Group Management Lp Column has been a net buyer of NGM stock. They have purchased $32.4M and sold $0 worth of shares.
Group Management Lp Column's most recent insider trade was on Jul 28, 2020, when they purchased 4,105 shares at $17.99 per share.
Get notified when new Form 4 filings are submitted
| $18.00 |
| Discretionary |
| Jul 21, 2020 | NGM | $320.4K | Option Exercise | 24,000 | $13.35 | Discretionary |
| Apr 7, 2020 | NGM | $1.8M | Purchase | 123,728 | $14.38 | Discretionary |
| Apr 3, 2020 | NGM | $181.0K | Purchase | 14,587 | $12.41 | Discretionary |
| Nov 4, 2019 | NGM | $100.8K | Purchase | 8,409 | $11.99 | Discretionary |
| Aug 2, 2019 | NGM | $24.9K | Purchase | 1,782 | $13.97 | Discretionary |
| Aug 1, 2019 | NGM | $36.3K | Purchase | 2,600 | $13.98 | Discretionary |
| Apr 8, 2019 | NGM | $0 | Conversion | 13,093,134 | $N/A | Discretionary |
| Apr 8, 2019 | NGM | $240.0K | Purchase | 15,000 | $16.00 | Discretionary |
| Apr 8, 2019 | NGM | $30.0M | Purchase | 1,875,000 | $16.00 | Discretionary |